Overcoming the two huge challenges of postoperative recovery and targeted drug resistance, experts will teach you how to win this battle against cancer!

A survey conducted by the National Health Commission shows that the five-year survival rate of malignant tumors in my country has increased from 30.9% ten years ago to 40.5%, an increase of nearly 10 percentage points[1].

This is a gratifying number. With the implementation of diversified treatment strategies such as chemotherapy, radiotherapy, surgery, targeted therapy and immunotherapy, long-term survival is no longer out of reach for patients with advanced non-small cell lung cancer.

However, there are still two major obstacles in the fight against cancer that affect the quality of life and survival of most lung cancer patients - postoperative complications and targeted drug resistance.

01

Postoperative complications

The stage is in the early stage, and surgical removal of the tumor can greatly improve the cure rate. Generally speaking, the earlier the stage of lung cancer, the higher the cure rate, and the 5-year survival rate can be as high as 92% [2].

Image source: Reference [2]

Despite such a high cure rate, 8%-35% of patients will still experience complications after surgery[3]. Common complications include respiratory complications (atelectasis and obstructive pulmonary emphysema), lung infection, bronchopleural fistula, etc. These complications may affect the quality of life at the mildest level and threaten life safety at the worst.

In addition to postoperative complications, some lung cancer patients will also encounter the mountain of targeted drug resistance during treatment!

02

Targeting the mountain of drug resistance

In the past, some lung cancer patients would think, how great it would be if there was a medicine in the world that could be taken once or twice a day to control the disease, like high blood pressure or diabetes.

Now this concept has been realized in some lung cancer patients through targeted drugs: taking medicine at regular times and in regular amounts every day can control the disease.

The emergence of targeted drugs has improved the quality of life of patients and also prolonged their survival. However, during the period of taking targeted drugs, patients will inevitably encounter some problems, such as:

Can I take other targeted drugs if I have already developed drug resistance? If targeted therapy is not possible, are there other treatments? Will my survival and quality of life be worse if I use other treatments?

03

Experts live broadcast to help fight cancer

In order to help everyone solve their confusion and clear the fog of anti-cancer, under the guidance of the Science Popularization Professional Committee of the China Anti-Cancer Association, Mijianfei Xiaofan opened the third "Feifan Power" in 2022 for Mijian friends with the theme of "Wind and Rain! How lung cancer overcomes the two mountains of postoperative recovery and targeted drug resistance" for science popularization live broadcast.

For this live broadcast, we are very honored to invite three lung cancer experts: Professor Ouyang Weiwei from the Department of Thoracic Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Professor Song Yongxiang from the Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, and Professor Wang Sixiong from the Department of Geriatric Oncology, Affiliated Cancer Hospital of Chongqing University.

Live Topic

In this live broadcast, Professor Song Yongxiang will discuss in detail with friends how to deal with complications after lung cancer surgery; Professor Ouyang Weiwei and Professor Wang Sixiong will also answer questions and solve problems for friends around two major themes to help fight cancer: what to do after targeted drug resistance, and popularization of lung cancer disease and diagnosis and treatment knowledge.

Live broadcast information

Live broadcast time

August 18, 17:00-19:00

Live broadcast appointment

Follow the Chinese Anti-Cancer Association's popular science platform and make an appointment for a live broadcast

Expert Profile

Professor Ouyang Weiwei

Director of the Department of Thoracic Oncology, Tumor Hospital Affiliated to Guizhou Medical University

Member of the Fifth Tumor Biotherapy Professional Committee of the Chinese Anti-Cancer Association

Standing member of the Radiotherapy Committee of the Geriatric Tumor Professional Committee of the Chinese Gerontological Society

The first member of the Chinese Medical Doctor Association Radiotherapy Physicians Branch

Member of the First Committee of Hyperthermia Professional Committee of Radiation Oncology Physicians Branch of Chinese Medical Doctor Association

The Second Council Member of the Western Radiotherapy Association

Member of the Thoracic Tumor Radiotherapy Committee of the Western Radiotherapy Association

Member of the Lung Cancer Professional Committee of the Southern China Association for Clinical Oncology Research

Vice Chairman of the Drug Clinical Trial Committee of Guizhou Pharmaceutical Association

Editorial Board Member of Practical Cancer Journal

Professor Song Yongxiang

Director of the Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University

Vice Chairman of the Tumor Surgery Committee of Guizhou Anti-Cancer Association

Standing Committee Member and Secretary of the Cardiothoracic Surgery Branch of Guizhou Medical Association

Deputy Director of Guizhou Provincial Thoracic and Cardiovascular Surgery and Thoracoscopy Medical Quality Control Center

Standing Committee Member of the Sympathetic Neurosurgery Committee of Wu Jieping Medical Foundation

Director of Zunyi Cardiothoracic Surgery Quality Control Center

Vice Chairman of the Thoracic and Cardiovascular Surgery Branch of Zunyi Medical Association

Standing Committee Member of Organ Transplantation Branch of Zunyi Medical Association

Professor Wang Sixiong

Deputy Director of Geriatric Oncology Department, Chongqing University Cancer Hospital

Member of the Tumor Nutrition Committee of the Chinese Anti-Cancer Association

Member of the Chemotherapy Committee of Chongqing Anti-Cancer Association

Teaching Secretary, Department of Medical Oncology

Member of the Palliative Care Medicine Committee of Chongqing Association of Integrated Traditional Chinese and Western Medicine

Participated in three National Natural Science Foundation research projects, presided over a key project of Chongqing Municipal Health Commission, and won a third prize for military scientific and technological progress

Expert in comprehensive medical treatment of malignant tumors such as lung cancer, gastric cancer, esophageal cancer, colorectal cancer, lymphoma, etc., especially chemotherapy, biological immunotherapy and molecular targeted therapy of tumors, as well as standardized chemotherapy treatment of cancer pain

end

There is no magic in the world that can instantly cure cancer.

Fighting cancer is a cycle of three steps forward and two steps back. Although cancer divides our lives into two parts, before cancer and after cancer, this boundary is gradually blurring after overcoming fear and learning about fighting cancer.

This is a relay race of life. No matter where the finish line is, as long as there is hope, please keep running!